Innovation for early detection and diagnosis of cancer event launches 22 November 2021 The one-day event held on 17 November was attended by more than 120 invited experts, key opinion leaders, practitioners and leaders from across sectors to explore trends at the fo
Pioneering wound care technology launches in Wales to transform patient experience 17 November 2021 Global technology company Healthy.io has launched the first use of their innovative wound care app in Wales, allowing patients to have their wounds assessed and monitored from the comfort of their own home.
New chair appointed for Life Sciences Hub Wales 23 August 2021 Dr Chris Martin becomes the new chair of Life Sciences Hub Wales. He succeeds Professor Sir Mansel Aylward who is stepping down from the role of chair but will continue as a non-executive director on the board.
Remote Cardiac Patient Monitoring Pilot launched in Wales 19 August 2021 Cwm Taf Morgannwg University Health Board (CTMUHB) and Betsi Cadwaladr University Health Board (BCUHB) have teamed up with Huma to pilot the remote monitoring of patients with cardiac issues (heart failure) across Wales via an app in their own homes.
The Accelerate programme is helping to transform Glanrhyd Church 18 August 2021 The Accelerate programme is supporting refurbishing Glanrhyd church into a space for the local communities to use.
Annual review reflects on the support of industry to health and care during Covid-19 28 June 2021 Life Sciences Hub Wales has published its Annual Review for 2020-21, highlighting its work and achievements during the past business year.
Wales Tech Week 21 June 2021 The festival sets to showcase how technology is impacting, enabling, and improving our lives, all from the comforts of your own home/office.
An Accelerate case study: Precision medicine based diagnosis of post-surgical complications in patients undergoing abdominal surgery Following a diagnosis of colorectal cancer, 63% of patients will undergo a colorectal resection with most patients having an anastomosis.
An Accelerate case study: Virucidal coatings in the battle against Covid-19: using biorefining waste technology to enhance PPE safety This project builds on a collaboration to develop naturally-derived virucidal actives by trying to assess the efficacy of coating formulations in rendering pandemic viruses immobile and destroying them on contact with a coated surface.
An Accelerate case study: Geko™ Venous thromboembolic diseases (VTE) are caused by a thrombus (blood clot) occurring in a vein. Patients are assessed for their VTE risk when they enter a hospital.
